CCChien Vien Chinh

Chien Vien Chinh

*This is an algorithmically generated author record based on publicly available information.

Chien Vien Chinh has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    New Data on Ixodid Ticks and Their Infection with Borrelia and Coxiella burnetii in Vietnam

    by Nguyen Van Hiep, Tatiana A. Bondarenko, Le Thi Lan Anh, Olga A. Stukolova, Luong Thi Mo, Kseniia A. Sycheva, Vien Chinh Chien, Alex L. Viskontene, Nguyen Thi Dung, Dmitriy V. Dubrovskiy, et al.

    The distribution of medically significant ticks in Vietnam requires ongoing monitoring. This study presents data on tick distribution and molecular screening for Borrelia spp. and Coxiella burnetii DNA. Ticks were collected from domestic animals and vegetation in four provinces over the period of 2024–2025. Species identification was performed based on morphology and confirmed by sequencing mitochondrial COI and 16S rRNA genes. A total of 2347 ticks were collected, representing eight species from the genera Haemaphysalis, Rhipicephalus, and Amblyomma. The study provides new distribution records for H. bispinosa, H. cornigera, A. integrum, and several rarely reported species (H. lagrangei, H. hystricus, and H. wellingtoni). PCR screening revealed a relatively high detection rate of Borrelia DNA in H. cornigera from Cao Bang province. Sequencing identified the pathogen as B. theileri, the agent of bovine borreliosis. Borrelia theileri was also detected in R. microplus in other regions, indicating wider circulation. PCR screening for Coxiella burnetii was positive for 13 ticks from cattle in Cao Bang province. To rule out false-positive results due to detection of DNA from Coxiella-like endosymbionts, we sequenced a fragment of the IS1111 element for three positive samples. The sequences confirmed that the DNA belongs to bacteria of the genus Coxiella, but the data do not allow confident assignment to C. burnetii at the species level. These positive ticks originated from eight neighboring households, suggesting a potential localized focus that requires further assessment in livestock and humans to determine the epidemiological significance. This research enhances the understanding of Vietnam’s tick fauna and associated pathogens of medical and veterinary importance.

  • Open Access

    Persistence of vaccine-induced antibodies to A/H5N1 at 30 months and 36 months after vaccination in Vietnam

    by Chien Vien Chinh, Viet Phu Quoc, Loc Huynh Tan, Duoc Nguyen Van, Thai Pham Quang, Be Le Van

    OBJECTIVES: An A/H5N1 vaccine (IVACFLU-A/H5N1) was accepted for use in Vietnam; however, antibody persistence after vaccination has not been well characterized. We examined post-vaccination antibody persistence and related risk factors in individuals enrolled in the phase II IVACFLU-A/ H5N1 vaccine trial in Ninh Hoa, Vietnam, who received a 15-μg dose (2 injections 21 days apart).METHODS: We used a longitudinal study design to follow 86 participants, without a control group. The participants tested as anti-A/H5N1 immunoglobulin G seronegative at baseline and received both doses of the vaccine. Blood was drawn at 30 months and 36 months after the complete vaccination to assess antibody status. Antibody persistence status was compared by demographic characteristics and exposure risk factors using univariate logistic regression.RESULTS: In total, 84.9% and 52.3% of the population showed persistence of at least 1/10 of the A/H5N1 antibodies at 30 months and 36 months after IVACFLU-A/H5N1 vaccination, respectively. The odds of antibody persistence were higher in older people, but lower in people who had experienced flu-like symptoms in the past 18 months or between 2 visits. We recorded no differences between A/H5N1 antibody persistence and exposure risk factors, including having a poultry farm, coming into contact with poultry, and slaughtering and processing poultry.CONCLUSIONS: This study demonstrated noteworthy antibody persistence, indicated by the seroconversion rate and geometric mean titer at 30 months and 36 months after the IVACFLU-A/H5N1 vaccine. Further studies should investigate older people and those who experienced flu-like symptoms to determine a suitable time for a booster shot.